Laboratory Corporation of America Holdings Stock
Equities
LH
US50540R4092
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
208 USD | +2.41% | +2.99% | -8.50% |
Financials (USD)
Sales 2024 * | 12.76B | Sales 2025 * | 13.31B | Capitalization | 17.08B |
---|---|---|---|---|---|
Net income 2024 * | 995M | Net income 2025 * | 1.11B | EV / Sales 2024 * | 1.68 x |
Net Debt 2024 * | 4.35B | Net Debt 2025 * | 3.85B | EV / Sales 2025 * | 1.57 x |
P/E ratio 2024 * |
17.1
x | P/E ratio 2025 * |
15.4
x | Employees | 61,975 |
Yield 2024 * |
1.46% | Yield 2025 * |
1.51% | Free-Float | 99.66% |
Latest transcript on Laboratory Corporation of America Holdings
1 day | +2.41% | ||
1 week | +2.99% | ||
Current month | -4.80% | ||
1 month | -2.70% | ||
3 months | -8.26% | ||
6 months | +5.07% | ||
Current year | -8.50% |
Managers | Title | Age | Since |
---|---|---|---|
Adam Schechter
CEO | Chief Executive Officer | 59 | 13-03-31 |
Glenn Eisenberg
DFI | Director of Finance/CFO | 62 | 14-06-15 |
Compliance Officer | 65 | 19-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Williams
BRD | Director/Board Member | 75 | 07-05-15 |
Adam Schechter
CEO | Chief Executive Officer | 59 | 13-03-31 |
Director/Board Member | 74 | 95-04-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.97% | 2 M€ | +5.19% | ||
1.95% | 8 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 203.1 | +0.79% | 685,960 |
24-04-19 | 201.5 | +1.02% | 768,208 |
24-04-18 | 199.4 | -0.26% | 769,005 |
24-04-17 | 200 | -0.97% | 683,299 |
24-04-16 | 201.9 | -0.68% | 691,528 |
Delayed Quote Nyse, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.50% | 17.08B | |
-13.25% | 87.77B | |
+18.01% | 82.08B | |
+11.97% | 30.03B | |
-1.46% | 16.41B | |
+4.44% | 12.37B | |
+5.11% | 12.17B | |
-31.05% | 11.89B | |
+27.83% | 11.62B | |
+8.18% | 10.85B |
- Stock Market
- Equities
- LH Stock